The executives at Pfizer PFE -0.07% and Johnson & Johnson JNJ -0.32% are giving each other headaches over an ad for a widely used pain reliever.
Here’s the story: Last fall, the J&J McNeil unit, which sells Tylenol and other over-the-counter medicines, objected to an ad in several medical journals for a pediatric form of Advil, a rival product sold by Pfizer. The McNeil team demanded Pfizer immediately yank its ad on the grounds that it violated a 1989 court order preventing ads that suggest an infant form Advil is “like” or “comparable” to Tylenol for infants.
Help employers find you! Check out all the jobs and post your resume.
